Facilitators and barriers of antiseizure medication adherence from Australian healthcare providers' perspectives: A qualitative study
Epilepsia Open · 2025
DOI: 10.1002/epi4.70110 ↗Kurz gefasst
Qualitative Studie in der Zeitschrift Epilepsia Open, 2025. Verfasst von Alison Conquest und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Translational Medicine, Monash University, Melbourne, Victoria, Australia. Hauptthemen laut MEDLINE: Anticonvulsants, Epilepsy, Medication Adherence, Health Personnel. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: BRAIN Foundation, Clive and Vera Ramaciotti Foundations, Royal Australasian College of Physicians (RACP) Foundation.
Abstract (Originalsprache)
Objectives
Antiseizure medications (ASMs) are the mainstay of epilepsy treatment. Two‐thirds of people with epilepsy can become seizure‐free with appropriately selected ASMs. Adherence to ASMs is crucial for achieving seizure control. Unfortunately, treatment gaps prevent many people from accessing or adhering to ASMs. We aimed to understand the factors that promote and hinder ASM adherence in a high‐income country, from healthcare providers' perspectives, and practical strategies to address these. Healthcare providers have accumulated decades of experience in the healthcare system through hundreds of patient encounters, and this study complements existing research focused on patients' perspectives.
Methods
Semi‐structured interviews were conducted with 16 purposively sampled epilepsy healthcare providers (GPs, epilepsy nurses, general neurologists, and epileptologists) each with 7–35 years' experience of managing epilepsy, located throughout Australia. Transcripts were inductively coded, thematically analyzed, and identified factors were mapped to the WHO's Five Dimensions of Medication Adherence framework: (i) patient‐related, (ii) condition‐related, (iii) therapy‐related, (iv) health systems‐related, and (v) social determinants of health.
Results
Twenty‐three barriers and 16 facilitators were identified across the WHO Five Dimensions. Key barriers included lifestyle factors, health beliefs, acceptance of the diagnosis, and long wait times with limited access to services. Facilitators included the provision of tailored, epilepsy‐specific information, strong clinician‐patient relationships, acting on patient‐identified goals and motivators, and integrated health systems. Personalized education and written materials were considered beneficial for patients' medication self‐management and adherence to medication regimens. The need for regular reviews and accessible healthcare services to support ongoing adherence was highlighted. Significance Addressing modifiable factors that influence ASM adherence is a pragmatic step to addressing epilepsy treatment gaps. Findings from this study, combined with knowledge gained from the lived experience of participants, may inform the co‐design of practical, point of care interventions to support medication adherence for people living with epilepsy. Plain Language Summary This study identified key facilitators and barriers of antiseizure medication adherence, according to epilepsy healthcare providers in Australia. Factors impacting medication adherence were mapped to the WHO's Five Dimensions of Medication Adherence. Identified facilitators and barriers to adherence included strong clinician‐patient relationships, seizure type and severity, lifestyle and life stage, adverse medication effects, and having good social support networks. This study may guide information and interventions designed to improve antiseizure medication adherence.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Translational Medicine, Monash University, Melbourne, Victoria, Australia.
- Department of Neurology, Alfred Health, Melbourne, Victoria, Australia.
- Department of Neurology, The Royal Melbourne Hospital, Parkville, Victoria, Australia.
- Menzies School of Health Research, Darwin, Northern Territory, Australia.
- Charles Darwin University, Darwin, Northern Territory, Australia.
- Western Australian Adult Epilepsy Service, Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia.
ORCID-Profile: Alison Conquest, Sameer Sharma, Patrick Kwan, Sandra Reeder, Emma Foster
Förderung
- BRAIN Foundation
- Clive and Vera Ramaciotti Foundations
- Royal Australasian College of Physicians (RACP) Foundation
- Ramaciotti Foundations
- Royal Australasian College of Physicians
Zitieren
APA
Conquest, A., Sharma, S., Lawn, N., Todd, L., Wait, L., Friderichs, M., Kwan, P., Reeder, S., & Foster, E. (2025). Facilitators and barriers of antiseizure medication adherence from Australian healthcare providers' perspectives: A qualitative study. Epilepsia Open. https://doi.org/10.1002/epi4.70110
Vancouver
Conquest A, Sharma S, Lawn N, Todd L, Wait L, Friderichs M, et al. Facilitators and barriers of antiseizure medication adherence from Australian healthcare providers' perspectives: A qualitative study. Epilepsia Open. 2025. doi:10.1002/epi4.70110
BibTeX
@article{Conquest2025,
author = {Conquest, Alison and Sharma, Sameer and Lawn, Nicholas and Todd, Lisa and Wait, Lisa and Friderichs, Mascha and Kwan, Patrick and Reeder, Sandra and Foster, Emma},
title = {Facilitators and barriers of antiseizure medication adherence from Australian healthcare providers' perspectives: A qualitative study},
journal = {Epilepsia Open},
year = {2025},
doi = {10.1002/epi4.70110}
}
EUVIMED